Cavallaro Francesca L, Duclos Diane, Baggaley Rebecca F, Penn-Kekana Loveday, Goodman Catherine, Vahanian Alice, Santos Andreia C, Bradley John, Paintain Lucy, Gallien Jérémie, Gasparrini Antonio, Hasselback Leah, Lynch Caroline A
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Department of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Reprod Health. 2016 Apr 21;13:45. doi: 10.1186/s12978-016-0163-7.
In Senegal, only 12% of women of reproductive age in union (WRAU) were using contraceptives and another 29% had an unmet need for contraceptives in 2010-11. One potential barrier to accessing contraceptives is the lack of stock availability in health facilities where women seek them. Multiple supply chain interventions have been piloted in low- and middle-income countries with the aim of improving contraceptive availability in health facilities. However, there is limited evidence on the effect of these interventions on contraceptive availability in facilities, and in turn on family planning use in the population. This evaluation protocol pertains to a supply chain intervention using performance-based contracting for contraceptive distribution that was introduced throughout Senegal between 2012 and 2015.
This multi-disciplinary research project will include quantitative, qualitative and economic evaluations. Trained researchers in the different disciplines will implement the studies separately but alongside each other, sharing findings throughout the project to inform each other's data collection. A non-randomised study with stepped-wedge design will be used to estimate the effect of the intervention on contraceptive stock availability in health facilities, and on the modern contraceptive prevalence rate among women in Senegal, compared to the current pull-based distribution model used for other commodities. Secondary data from annual Service Provision Assessments and Demographic and Health Surveys will be used for this study. Data on stock availability and monthly family planning consultations over a 4-year period will be collected from 200 health facilities in five regions to perform time series analyses. A process evaluation will be conducted to understand the extent to which the intervention was implemented as originally designed, the acceptability of third-party logisticians within the health system and potential unintended consequences. These will be assessed using monthly indicator data from the implementer and multiple ethnographic methods, including in-depth interviews with key informants and stakeholders at all levels of the distribution system, observations of third-party logisticians and clinic diaries. An economic evaluation will estimate the cost of the intervention, as well as its cost-effectiveness compared to the current supply chain model.
Given the very limited evidence base, there is an important need for a comprehensive standardised approach to evaluating supply chain management, and distribution specifically. This evaluation will help address this evidence gap by providing rigorous evidence on whether private performance-based contracting for distribution of contraceptives can contribute to improving access to family planning in low- and middle-income countries.
在塞内加尔,2010 - 2011年期间,只有12%的处于婚姻关系中的育龄妇女(WRAU)使用避孕药具,另有29%的妇女有未满足的避孕药具需求。获取避孕药具的一个潜在障碍是妇女寻求服务的医疗机构缺乏库存。在低收入和中等收入国家已经试点了多种供应链干预措施,目的是提高医疗机构的避孕药具可及性。然而,关于这些干预措施对医疗机构避孕药具可及性的影响,以及进而对人群计划生育使用情况的影响,证据有限。本评估方案涉及一项在2012年至2015年期间在塞内加尔全国推行的基于绩效合同的避孕药具配送供应链干预措施。
这个多学科研究项目将包括定量、定性和经济评估。不同学科的经过培训的研究人员将分别但同时开展研究,在整个项目过程中分享研究结果以相互为对方的数据收集提供信息。将采用带有阶梯楔形设计的非随机研究来估计该干预措施对医疗机构避孕药具库存可及性以及塞内加尔妇女现代避孕普及率的影响,并与目前用于其他商品的基于拉动式的配送模式进行比较。本研究将使用年度服务提供评估和人口与健康调查的二手数据。将从五个地区的200家医疗机构收集为期4年的库存可及性数据和每月计划生育咨询数据,以进行时间序列分析。将开展一项过程评估,以了解干预措施按原设计实施的程度、第三方物流在卫生系统中的可接受性以及潜在的意外后果。将使用实施方提供的月度指标数据和多种人种学方法进行评估,包括对各级配送系统的关键信息提供者和利益相关者进行深入访谈、对第三方物流进行观察以及诊所日志记录。一项经济评估将估计干预措施的成本,以及与当前供应链模式相比的成本效益。
鉴于证据基础非常有限,迫切需要一种全面的标准化方法来评估供应链管理,特别是配送。本评估将通过提供关于基于绩效的私人避孕药具配送合同是否有助于改善低收入和中等收入国家计划生育服务可及性的严格证据,来帮助填补这一证据空白。